Senior VP, Research and Innovation at Abcam, UK

BIO

Mark Bushfield is the SVP for Research and Innovation at Abcam, where he leads the new product development and long-term R&D activities.  His group uses a combination of rabbit hybridoma, next generation sequencing and phage display technologies to accelerate the development of highly validated recombinant binders for use by life sciences researchers, as well as the development of multiplex detection technologies to quantify changes in protein and miRNA biomarker levels.  Prior to joining Abcam, Mark spent almost 20 years leading Pharma and Biotech R&D teams at Pfizer, then Cambridge Drug Discovery and UCB-Celltech.

MORE INFO

Visit the website

Speaker at